Vor Biopharma (VOR) Shares Outstanding (Diluted Average) (2021 - 2026)

Vor Biopharma (VOR) has 6 years of Shares Outstanding (Diluted Average) data on file, last reported at $43.0 million in Q1 2026.

• Quarterly Shares Outstanding (Diluted Average) rose 589.15% year-over-year to $43.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $43.0 million (up 589.15% YoY) and the FY2025 annual result came in at $9.9 million, up 187.35% from the prior year.
• Shares Outstanding (Diluted Average) climbed to $43.0 million in Q1 2026 per VOR's latest filing, from $9.9 million in the prior quarter.
• Across five years, Shares Outstanding (Diluted Average) topped out at $125.0 million in Q2 2025 and bottomed at $3.4 million in Q3 2024.
• The 5-year median for Shares Outstanding (Diluted Average) is $39.6 million (2022), against an average of $44.3 million.
• The widest annual swing landed in 2024, when Shares Outstanding (Diluted Average) sank 94.95%; it then surged 589.15% in 2026.
• Tracing VOR's Shares Outstanding (Diluted Average) over 5 years: stood at $39.6 million in 2022, then jumped by 69.89% to $67.2 million in 2023, then plunged by 94.89% to $3.4 million in 2024, then surged by 187.35% to $9.9 million in 2025, then surged by 335.7% to $43.0 million in 2026.
• Per Business Quant, the three latest VOR Shares Outstanding (Diluted Average) figures stand at $43.0 million (Q1 2026), $9.9 million (Q4 2025), and $6.7 million (Q3 2025).

Peer Comparison